We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.68%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$39B
AUM Growth
-$220M
(-0.56%)
Cap. Flow
+$1.59B
Cap. Flow
% of AUM
4.06%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,663
New
306
Increased
844
Reduced
1,189
Closed
301
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$592M |
| 2 |
Tesla
TSLA
|
+$492M |
| 3 |
Amazon
AMZN
|
+$474M |
| 4 |
Advanced Micro Devices
AMD
|
+$410M |
| 5 |
Qualcomm
QCOM
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$393M |
| 2 |
Union Pacific
UNP
|
+$363M |
| 3 |
Walmart Inc
WMT
|
+$239M |
| 4 |
Citigroup
C
|
+$192M |
| 5 |
ConocoPhillips
COP
|
+$172M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.84% |
| 2 | Healthcare | 15.27% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Industrials | 10.47% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Gold Royalty Corp
GROY
$598M
| $67.5K | ﹤0.01% |
52,700
-8,700
| -14% | -$13.8K |
|
|
GBIO
2252
DELISTED
Generation Bio
GBIO
| $67.1K | ﹤0.01% |
1,770
-980
| -36% | -$46.4K |
|
2253
Caribou Biosciences
CRBU
$148M
| $66.9K | ﹤0.01% |
+14,000
| New | +$86.9K |
|
|
CBD
2254
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $64.5K | ﹤0.01% |
96,700
-270,200
| -74% | -$807K |
|
|
DOYU
2255
DouYu International Holdings
DOYU
$140M
| $64.2K | ﹤0.01% |
6,590
-3,060
| -32% | -$32K |
|
|
SOL
2256
DELISTED
Emeren Group
SOL
| $64.1K | ﹤0.01% |
+20,800
| New | +$72.2K |
|
2257
Sundial Growers
SNDL
$318M
| $63.5K | ﹤0.01% |
+33,400
| New | +$56.2K |
|
2258
Gaia
GAIA
$47.6M
| $63.1K | ﹤0.01% |
23,200
-200
| -0.9% | -$479 |
|
|
CTLP
2259
DELISTED
Cantaloupe
CTLP
| $62.5K | ﹤0.01% |
+10,000
| New | +$73.3K |
|
2260
LG Display
LPL
$2.93B
| $62.5K | ﹤0.01% |
12,800
| – | – |
|
2261
VirnetX Holding Corp
VHC
$54.4M
| $62.3K | ﹤0.01% |
12,251
+5,730
| +88% | +$44.3K |
|
2262
Vuzix
VUZI
$187M
| $61.7K | ﹤0.01% |
17,000
-7,700
| -31% | -$34.1K |
|
|
AUTL
2263
Autolus Therapeutics
AUTL
$386M
| $58.5K | ﹤0.01% |
25,100
-1,300
| -5% | -$3.7K |
|
2264
Edgewise Therapeutics
EWTX
$4.34B
| $58.4K | ﹤0.01% |
+10,200
| New | +$69.3K |
|
2265
Standard BioTools
LAB
$311M
| $57.7K | ﹤0.01% |
19,900
-10,200
| -34% | -$26.7K |
|
2266
OmniAb
OABI
$286M
| $57.4K | ﹤0.01% |
11,050
-4,000
| -27% | -$21.3K |
|
2267
Cardiff Oncology
CRDF
$63.6M
| $57K | ﹤0.01% |
41,000
-131,800
| -76% | -$222K |
|
2268
Alaunos Therapeutics
TCRT
$4.64M
| $56.8K | ﹤0.01% |
2,875
-1,380
| -32% | -$59.5K |
|
2269
ALX Oncology
ALXO
$268M
| $55.7K | ﹤0.01% |
11,600
-34,600
| -75% | -$188K |
|
|
CLSD
2270
DELISTED
Clearside Biomedical
CLSD
| $54.7K | ﹤0.01% |
4,193
-2,480
| -37% | -$37.6K |
|
2271
Stoke Therapeutics
STOK
$1.83B
| $54.4K | ﹤0.01% |
+13,800
| New | +$90.7K |
|
2272
GrowGeneration
GRWG
$88.3M
| $53.7K | ﹤0.01% |
18,400
+1,500
| +9% | +$4.92K |
|
|
CDTX
2273
DELISTED
Cidara Therapeutics
CDTX
| $52K | ﹤0.01% |
2,760
-1,070
| -28% | -$21K |
|
|
ELEV
2274
DELISTED
Elevation Oncology
ELEV
| $50.9K | ﹤0.01% |
+76,800
| New | +$77.7K |
|
|
NOTV
2275
DELISTED
Inotiv
NOTV
| $50.5K | ﹤0.01% |
16,400
+3,300
| +25% | +$15.1K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, Two Sigma Advisers held 2,663 positions worth $39B, down 0.56% from $39.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Two Sigma Advisers deployed $1.59B of net new capital in Q3 2023, opening 306 new positions and adding to 844 existing holdings. Its largest new stake was Advanced Micro Devices: 3,777,240 shares worth $388M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Charles Schwab, an estimated $393M trimmed.
- Two Sigma Advisers's largest Q3 2023 buy was Advanced Micro Devices: 3,777,240 shares worth $388M.
- Two Sigma Advisers added most to Microsoft in Q3 2023, an estimated $592M increase.
- Two Sigma Advisers's biggest Q3 2023 reduction was Charles Schwab, cutting an estimated $393M.
- Two Sigma Advisers fully exited Uber in Q3 2023, selling an estimated $109M.
- Two Sigma Advisers's ten largest holdings make up 16% of its $39B portfolio in Q3 2023.
- Two Sigma Advisers opened 306 new positions and closed 301 in Q3 2023.
- Two Sigma Advisers's portfolio value fell 0.56% quarter-over-quarter to $39B.
Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.